{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Immix Biopharma, Inc."},"Symbol":{"label":"Symbol","value":"IMMX"},"Address":{"label":"Address","value":"11400 WEST OLYMPIC BOULEVARD,SUITE 200, LOS ANGELES, California, 90064, United States"},"Phone":{"label":"Phone","value":"+1 310 651-8041"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Immix Biopharma Inc is a clinical-stage biopharmaceutical company developing Tissue-Specific Therapeutics in oncology and inflammation."},"CompanyUrl":{"label":"Company Url","value":"https://www.immixbio.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Graham Ross","title":"Chief Medical Officer & Head-Clinical Development"},{"name":"Ilya Rachman","title":"Chairman & Chief Executive Officer"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}